Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of SHR-1209 in Homozygous Familial Hypercholesterolemia
CTR20201551Phase 2Completed
- Sponsor
- Suzhou Sundia Biotech Co., Ltd.
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recaticimab in homozygous familial hypercholesterolemia (HoFH), sponsored by Suzhou Sundia Biotech Co., Ltd.. Started Jul 2020; status: completed.
02
Drugs
recaticimab
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on CTR20201551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201551.